Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic Strategies
NCT ID: NCT05213988
Last Updated: 2022-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2018-07-30
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes
NCT01025856
The Impact of Macronutrient Composition on Glucose Dynamics in Persons With Type 1 Diabetes
NCT05268705
Dietary Interventions in Prediabetes
NCT01729078
Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity
NCT05181514
Mediterranean Diet and Postprandial Lipemia
NCT00789295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-Carbohydrate/High-Protein Diet
Low-Carbohydrate/High-Protein diet
Low-calorie, low-carbohydrate, high-protein diet
Fibrate
Fibrates
Bezafibrate 400 mg/day
Intermittent Fasting
Intermittent Fasting
Intermittent fasting meal pattern
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent Fasting
Intermittent fasting meal pattern
Fibrates
Bezafibrate 400 mg/day
Low-Carbohydrate/High-Protein diet
Low-calorie, low-carbohydrate, high-protein diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* both males and females
Exclusion Criteria
* pregnancy
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero, Universitaria Pisana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Natali
Full Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Natali, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pisa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliero-Universitaria Pisana
Pisa, PI, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GLUCO-STAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.